Catalytic sites can be placed at the core, at interior positions or at the periphery of a dendrimer. There are many examples of the use of peripherally functionalised dendrimers in catalysis and this subject has been thoroughly reviewed in the recent literature. This review is concerned only with dendrimer based catalysis involving catalytic sites at the core of a dendrimer and within the interior voids. In covering the significant achievements in this area, we have concentrated on examples that highlight key features with respect to positive and/or negative catalytic activity.
Nature uses the principles of encapsulation and supramolecular chemistry to bind and orientate substrates within active catalytic sites. Over the years, synthetic chemistry has generated a number of small molecule active site mimics capable of catalysing reactions involving bound substrates. Another approach uses larger molecules that better represent an enzymes globular structure. These molecules mimic an enzymes structure by incorporating binding/catalytic sites within the globular structure of the polymer. As such, the electronic and steric properties around the binding/catalytic site(s) can be controlled and fine-tuned. One class of polymer that is particularly adept at mimicking the globular structure of enzymes are dendritic polymers. This review will concentrate on the use of hyperbranched polymers as synthetic enzyme mimics.
Despite the technological advancement in the biomedical science, cancer remains a life-threatening disease. In this study, we designed an anticancer nanodelivery system using graphene oxide (GO) as nanocarrier for an active anticancer agent gallic acid (GA). The successful formation nanocomposite (GOGA) was characterized using XRD, FTIR, HRTEM, Raman, and UV/Vis spectroscopy. The release study shows that the release of GA from the designed anticancer nanocomposite (GOGA) occurs in a sustained manner in phosphate-buffered saline (PBS) solution at pH 7.4. In in vitro biological studies, normal fibroblast (3T3) and liver cancer cells (HepG2) were treated with different concentrations of GO, GOGA, and GA for 72 h. The GOGA nanocomposite showed the inhibitory effect to cancer cell growth without affecting normal cell growth. The results of this research are highly encouraging to go further for in vivo studies.
The hetero-Diels–Alder reaction between a pyridylbutadiene and 3-nitrosopyridine is accelerated by a variety of metalloporphyrin trimers; there is a weak correlation between rate acceleration and product binding strength.